                         SEQUENCE LISTING

<110>  AbSci LLC
 
<120>  ACTIVITY-SPECIFIC CELL ENRICHMENT

<130>  10294-105653-01

<150>  US 62/961,392
<151>  2020-01-15

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  5304
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Expression vector

<400>  1
ggcctttctt cggtagaagt cttcccccag aggcaggtat caaaggatct tcttgagatc       60

ctttttttct gcgcgtaatc tgctgcttgc aaacaaaaaa accaccgcta ccagcggtgg      120

tttgtttgcc ggatcaagag ctaccaactc tttttccgag gtaactggct tcagcagagc      180

gcagatacca aatactgttc ttctagtgta gccgtagtta ggccaccact tcaagaactc      240

tgtagcaccg cctacatacc tcgctctgct aatcctgtta ccagtggctg ctgccagtgg      300

cgataagtcg tgtcttaccg ggttggactc aagacgatag ttaccggata aggcgcagcg      360

gtcgggctga acggggggtt cgtgcacaca gcccagcttg gagcgaacga cctacaccga      420

actgagatac ctacagcgtg agctatgaga aagcgccacg cttcccgaag ggagaaaggc      480

ggacaggtat ccggtaagcg gcagggtcgg aacaggagag cgcacgaggg agcttccagg      540

gggaaacgcc tggtatcttt atagtcctgt cgggtttcgc cacctctgac ttgagcatcg      600

atttttgtga tgctcgtcag gggggcggag cctatggaaa aacgccagca acgcagaaag      660

gcccacccga aggtgagcca ggtgattaca tttgggccct catcagaggt tttcaccgtc      720

atcaccgaaa cgcgcgaggc agctgcggta aagctcatca gcgtggtcgt gaagcgattc      780

acagatgtct gcctgttcat ccgcgtccag ctcgttgagt ttctccagaa gcgttaatgt      840

ctggcttctg ataaagcggg ccatgttaag ggcggttttt tcctgtttgg tcatacctgc      900

ttagaaaaac tcatcgagca tcaaatgaaa ttgcaattta ttcatatcag gattatcaat      960

accatatttt tgaaaaagcc gtttctgtaa tgaaggagaa aactcaccga ggcagttcca     1020

taggatggca agatcctggt atcggtctgc gattccgact cgtccaacat caatacaacc     1080

tattaatttc ccctcgtcaa aaataaggtt atcaagtgag aaatcaccat gagtgacgac     1140

tgaatccggt gagaatggca aaagtttatg catttctttc cagacttgtt caacaggcca     1200

gccattacgc tcgtcatcaa aatcactcgc atcaaccaaa ccgttattca ttcgtgattg     1260

cgcctgagcg aggcgaaata cgcgatcgct gttaaaagga caattacaaa caggaatcga     1320

gtgcaaccgg cgcaggaaca ctgccagcgc atcaacaata ttttcacctg aatcaggata     1380

ttcttctaat acctggaacg ctgtttttcc ggggatcgca gtggtgagta accatgcatc     1440

atcaggagta cggataaaat gcttgatggt cggaagtggc ataaattccg tcagccagtt     1500

tagtctgacc atctcatctg taacatcatt ggcaacgcta cctttgccat gtttcagaaa     1560

caactctggc gcatcgggct tcccatacaa gcgatagatt gtcgcacctg attgcccgac     1620

attatcgcga gcccatttat acccatataa atcagcatcc atgttggaat ttaatcgcgg     1680

cctcgacgtt tcccgttgaa tatggctcat agctcctgaa aatctcgata actcaaaaaa     1740

tacgcccggt agtgatctta tttcattatg gtgaaagttg gaacctctta cgtgccgatc     1800

aagaagacgg tcaaaagcct ccggtcggag gccgggagag tgttcaccga caaacaacag     1860

ataaaacaaa aggcccagtc ttccgactga gccttttgtt ttatttgatg tctggcagtt     1920

cccgagacgt tatgacaact tgacggctac atcattcact ttttcttcac aaccggcacg     1980

gaactcgctc gggctggccc cggtgcattt tttaaatacc cgcgagaaat agagttgatc     2040

gtcaaaacca acattgcgac cgacggtggc gataggcatc cgggtggtgc tcaaaagcag     2100

cttcgcctgg ctgatacgtt ggtcctcgcg ccagcttaag acgctaatcc ctaactgctg     2160

gcggaaaaga tgtgacagac gcgacggcga caagcaaaca tgctgtgcga cgctggcgat     2220

atcaaaattg ctgtctgcca ggtgatcgct gatgtactga caagcctcgc gtacccgatt     2280

atccatcggt ggatggagcg actcgttaat cgcttccatg cgccgcagta acaattgctc     2340

aagcagattt atcgccagca gctccgaata gcgcccttcc ccttgcccgg cgttaatgat     2400

ttgcccaaac aggtcgctga aatgcggctg gtgcgcttca tccgggcgaa agaaccccgt     2460

attggcaaat attgacggcc agttaagcca ttcatgccag taggcgcgcg gacgaaagta     2520

aacccactgg tgataccatt cgcgagcctc cggatgacga ccgtagtgat gaatctctcc     2580

tggcgggaac agcaaaatat cacccggtcg gcaaacaaat tctcgtccct gatttttcac     2640

caccccctga ccgcgaatgg tgagattgag aatataacct ttcattccca gcggtcggtc     2700

gataaaaaaa tcgagataac cgttggcctc aatcggcgtt aaacccgcca ccagatgggc     2760

attaaacgag tatcccggca gcaggggatc attttgcgct tcagccatac ttttcatact     2820

cccgccattc agagaagaaa ccaattgtcc atattgcatc agacattgcc gtctctgcgt     2880

cttttactgg ctcttctcgc taaccaaacc ggtaaccccg cttattaaaa gcattctgta     2940

acaaagcggg accaaagcca tgacaaaaac gcgtaacaaa agtgtctata atcacggcag     3000

aaaagtccac attgattatt tgcacggcgt cacactttgc tatgccatag catttttatc     3060

cataagatta gcggatccta cctgacgctt tttatcgcaa ctctctactg tttctccata     3120

cccgtttttt tgggctagca ggaggtaaaa aaaatgtgag accggtctcg gtctagatcg     3180

gtcagtttca cctgatttac gtaaaaaccc gcttcggcgg gtttttgctt ttggaggggc     3240

agaaagatga atgactgtct ctcctgttag tgagggttaa tgcccggaac gaagaaaggc     3300

ccacccgtga aggtgagcca gtgagttggt tacattttct cttgagggtt tagcttttca     3360

gacgacgcca aaaggtcgta cgtgaaatac ccaaatagtt ggccgcagcc gtcttgtcac     3420

cattaaactt ctcaagcgct tgctgcgggg tcagcaaacg cggagccggc gtctttgcgc     3480

tctcacgcgc cagctccggc agcagcaact gcatgaattg cggagtcaga tccggggtcg     3540

gctcaacgga caggaacagc gccaggcgtt ccatcatatt acgcagctcg cggatgttac     3600

ccggccagtc ataatgcagc agcaccgttt cgctcgcctg cagaccctgg cgcagtgccg     3660

cagagaacgg tgcgctcagg gctgccagcg agactttcag gaaagactcc gccagcggta     3720

aaatgtcggc gacacgttca cgcaacggcg ggagctgcag acgcagaatg ctcaggcggt     3780

agaacaggtc gcgacgaaaa cggccctgtt gcatatcctc ttccagattg cagtgggtcg     3840

cgctaatcac gcgcacgtct accggaaccg gttgatgacc accgacgcgg gtcacttctt     3900

tctcttccag cacacgcagc agacgggttt gcaatggcag cggcatctca ccgatctcgt     3960

ccaggaacaa ggtgccgccg tgggcaattt caaacaaacc agcacggcca ccgcgacggc     4020

tacccgtgaa tgcgccctct tcgtagccaa acagctcagc ttccagcagg ctttccgcga     4080

ttgcaccgca attaactgcc acaaacggat gagatttctt accctggcgg gcatcgtgac     4140

gggcgaaata ctcacgatgg attgcttgcg cagccagttc cttacccgta ccagtctcgc     4200

cttcgatcag aacagccgcg ctgctacgtg catacagcag aatggtctgg cgaacttgct     4260

ccatttgagg gctttggccc agcatatcac ccaggacata acgggtacgc agcgcattac     4320

gcgtcgcatc gtgggtgttg tggcgcaggc tcattctggt catgtccagg gcgtcgctga     4380

acgcctgacg caccgttgcc gcgctgtaga taaagatgcc cgtcatgccc gcttcttcgg     4440

ccaagtccgt gatcagaccc gcaccaacca cagcctcggt accgttcgct ttcagttcgt     4500

tgatctggcc acgtgcatct tcctcggtaa tgtagctgcg ttggtccagg cgcagattaa     4560

aggtcttttg aaacgcgacc agcgcaggga tcgtttcctg gtaggtgaca acgccaatcg     4620

aggaggtcag tttgcctgcc ttcgccagcg cctgcaagac atcgtaaccg ctcggcttaa     4680

tcaggatcac cggcacggac agacgggatt tcaggtaggc accattgcta cccgctgcga     4740

taatggcgtc acaacgctcg ttggccagct ttttgcgaat gtaggtaacg gctttctcga     4800

aacccagctg aatcggagtg atgttcgcca ggtgatcaaa ctccaggcta atgtcgcgga     4860

acaactcgaa cagacgggtg acgctaacgg tccaaataac tggtttatca tcgttcaaac     4920

gcggtgggtg tgccatggtg aatacctcct gttaagaaac cgaatattgg gtttaaactt     4980

gtttcataat tgttgcaatg aaacgcggtg aaacattgcc tgaaacgtta actgaaacgc     5040

atatttgcgg attagttcat gactttatct ctaacaaatt gaaattaaac atttaatttt     5100

attaaggcaa ttgtggcaca ccccttgctt tgtctttatc aacgcaaata acaagttgat     5160

aacaaaagct taggaggaaa acatagagac cggtctctct cgagtaacta gttgatagag     5220

atcaagcctt aacgaactaa gacccccgca ccgaaaggtc cgggggtttt ttttgacctt     5280

aaaaacataa ccgaggagca gaca                                            5304


<210>  2
<211>  229
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Trastuzumab-Fab heavy chain A2

<400>  2

Met Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly 
1               5                   10                  15      


Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Lys Asp 
            20                  25                  30          


Thr Tyr Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Val Ala Arg Ile Tyr Pro Thr Asn Gly Tyr Thr Arg Tyr Ala Asp Ser 
    50                  55                  60                  


Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ser Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser 
        115                 120                 125             


Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala 
    130                 135                 140                 


Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val 
145                 150                 155                 160 


Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala 
                165                 170                 175     


Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val 
            180                 185                 190         


Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His 
        195                 200                 205             


Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Pro Lys Ser 
    210                 215                 220                 


Cys Asp Lys Thr His 
225                 


<210>  3
<211>  215
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Trastuzumab-Fab light chain A2

<400>  3

Met Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val 
1               5                   10                  15      


Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Asn Thr 
            20                  25                  30          


Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln His Tyr Thr Thr Pro 
                85                  90                  95      


Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala 
            100                 105                 110         


Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser 
        115                 120                 125             


Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu 
    130                 135                 140                 


Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser 
145                 150                 155                 160 


Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu 
                165                 170                 175     


Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val 
            180                 185                 190         


Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys 
        195                 200                 205             


Ser Phe Asn Arg Gly Glu Cys 
    210                 215 


<210>  4
<211>  228
<212>  PRT
<213>  Escherichia coli

<400>  4

Met Ala Ile Thr Ile Ser His Arg Lys Gln Thr Met Asp Asp Ala Ala 
1               5                   10                  15      


Ile Gln Gln Thr Leu Ala Lys Met Gly Ile Lys Ser Ser Asp Ile Gln 
            20                  25                  30          


Pro Ala Pro Val Ala Gly Met Lys Thr Val Leu Thr Asn Ser Gly Val 
        35                  40                  45              


Leu Tyr Ile Thr Asp Asp Gly Lys His Ile Ile Gln Gly Pro Met Tyr 
    50                  55                  60                  


Asp Val Ser Gly Thr Ala Pro Val Asn Val Thr Asn Lys Met Leu Leu 
65                  70                  75                  80  


Lys Gln Leu Asn Ala Leu Glu Lys Glu Met Ile Val Tyr Lys Ala Pro 
                85                  90                  95      


Gln Glu Lys His Val Ile Thr Val Phe Thr Asp Ile Thr Cys Gly Tyr 
            100                 105                 110         


Cys His Lys Leu His Glu Gln Met Ala Asp Tyr Asn Ala Leu Gly Ile 
        115                 120                 125             


Thr Val Arg Tyr Leu Ala Phe Pro Arg Gln Gly Leu Asp Ser Asp Ala 
    130                 135                 140                 


Glu Lys Glu Met Lys Ala Ile Trp Cys Ala Lys Asp Lys Asn Lys Ala 
145                 150                 155                 160 


Phe Asp Asp Val Met Ala Gly Lys Ser Val Ala Pro Ala Ser Cys Asp 
                165                 170                 175     


Val Asp Ile Ala Asp His Tyr Ala Leu Gly Val Gln Leu Gly Val Ser 
            180                 185                 190         


Gly Thr Pro Ala Val Val Leu Ser Asn Gly Thr Leu Val Pro Gly Tyr 
        195                 200                 205             


Gln Pro Pro Lys Glu Met Lys Glu Phe Leu Asp Glu His Gln Lys Met 
    210                 215                 220                 


Thr Ser Gly Lys 
225             


<210>  5
<211>  228
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  bicistronic Trastuzumab-Fab heavy chain A3

<400>  5

Met Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly 
1               5                   10                  15      


Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Asn Ile Lys Asp 
            20                  25                  30          


Thr Tyr Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp 
        35                  40                  45              


Val Ala Arg Ile Tyr Pro Thr Asn Gly Tyr Thr Arg Tyr Ala Asp Ser 
    50                  55                  60                  


Val Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ser Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser 
        115                 120                 125             


Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala 
    130                 135                 140                 


Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val 
145                 150                 155                 160 


Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala 
                165                 170                 175     


Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val 
            180                 185                 190         


Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His 
        195                 200                 205             


Lys Pro Ser Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys 
    210                 215                 220                 


Asp Lys Thr His 
225             


<210>  6
<211>  215
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  bicistronic Trastuzumab-Fab light chain A3

<400>  6

Met Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val 
1               5                   10                  15      


Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Asn Thr 
            20                  25                  30          


Ala Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser 
    50                  55                  60                  


Gly Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln His Tyr Thr Thr Pro 
                85                  90                  95      


Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala 
            100                 105                 110         


Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser 
        115                 120                 125             


Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu 
    130                 135                 140                 


Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser 
145                 150                 155                 160 


Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu 
                165                 170                 175     


Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val 
            180                 185                 190         


Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys 
        195                 200                 205             


Ser Phe Asn Arg Gly Glu Cys 
    210                 215 


<210>  7
<211>  396
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Trastuzumab-Fab heavy chain with an N-terminal amino acid 
       sequence derived from Synechocystis sp. DnaB

<400>  7

Met Ala Ile Ser Gly Asp Ser Leu Ile Ser Leu Ala Ser Thr Gly Lys 
1               5                   10                  15      


Arg Val Ser Ile Lys Asp Leu Leu Asp Glu Lys Asp Phe Glu Ile Trp 
            20                  25                  30          


Ala Ile Asn Glu Gln Thr Met Lys Leu Glu Ser Ala Lys Val Ser Arg 
        35                  40                  45              


Val Phe Cys Thr Gly Lys Lys Leu Val Tyr Ile Leu Lys Thr Arg Leu 
    50                  55                  60                  


Gly Arg Thr Ile Lys Ala Thr Ala Asn His Arg Phe Leu Thr Ile Asp 
65                  70                  75                  80  


Gly Trp Lys Arg Leu Asp Glu Leu Ser Leu Lys Glu His Ile Ala Leu 
                85                  90                  95      


Pro Arg Lys Leu Glu Ser Ser Ser Leu Gln Leu Ala Ser Gly His His 
            100                 105                 110         


His His His His Gly Gly Ser Gly Ser Ser Pro Glu Ile Glu Lys Leu 
        115                 120                 125             


Ser Gln Ser Asp Ile Tyr Trp Asp Ser Ile Val Ser Ile Thr Glu Thr 
    130                 135                 140                 


Gly Val Glu Glu Val Phe Asp Leu Thr Val Pro Gly Pro His Asn Phe 
145                 150                 155                 160 


Val Ala Asn Asp Ile Ile Val His Asn Glu Val Gln Leu Val Glu Ser 
                165                 170                 175     


Gly Gly Gly Leu Val Gln Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala 
            180                 185                 190         


Ala Ser Gly Phe Asn Ile Lys Asp Thr Tyr Ile His Trp Val Arg Gln 
        195                 200                 205             


Ala Pro Gly Lys Gly Leu Glu Trp Val Ala Arg Ile Tyr Pro Thr Asn 
    210                 215                 220                 


Gly Tyr Thr Arg Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser 
225                 230                 235                 240 


Ala Asp Thr Ser Lys Asn Thr Ala Tyr Leu Gln Met Asn Ser Leu Arg 
                245                 250                 255     


Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ser Arg Trp Gly Gly Asp Gly 
            260                 265                 270         


Phe Tyr Ala Met Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser 
        275                 280                 285             


Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser 
    290                 295                 300                 


Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp 
305                 310                 315                 320 


Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr 
                325                 330                 335     


Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr 
            340                 345                 350         


Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln 
        355                 360                 365             


Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp 
    370                 375                 380                 


Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His 
385                 390                 395     


<210>  8
<211>  383
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Trastuzumab-Fab light chain with an N-terminal amino acid 
       sequence derived from Synechocystis sp. DnaB

<400>  8

Met Ala Ile Ser Gly Asp Ser Leu Ile Ser Leu Ala Ser Thr Gly Lys 
1               5                   10                  15      


Arg Val Ser Ile Lys Asp Leu Leu Asp Glu Lys Asp Phe Glu Ile Trp 
            20                  25                  30          


Ala Ile Asn Glu Gln Thr Met Lys Leu Glu Ser Ala Lys Val Ser Arg 
        35                  40                  45              


Val Phe Cys Thr Gly Lys Lys Leu Val Tyr Ile Leu Lys Thr Arg Leu 
    50                  55                  60                  


Gly Arg Thr Ile Lys Ala Thr Ala Asn His Arg Phe Leu Thr Ile Asp 
65                  70                  75                  80  


Gly Trp Lys Arg Leu Asp Glu Leu Ser Leu Lys Glu His Ile Ala Leu 
                85                  90                  95      


Pro Arg Lys Leu Glu Ser Ser Ser Leu Gln Leu Ala Ser Gly His His 
            100                 105                 110         


His His His His Gly Gly Ser Gly Ser Ser Pro Glu Ile Glu Lys Leu 
        115                 120                 125             


Ser Gln Ser Asp Ile Tyr Trp Asp Ser Ile Val Ser Ile Thr Glu Thr 
    130                 135                 140                 


Gly Val Glu Glu Val Phe Asp Leu Thr Val Pro Gly Pro His Asn Phe 
145                 150                 155                 160 


Val Ala Asn Asp Ile Ile Val His Asn Asp Ile Gln Met Thr Gln Ser 
                165                 170                 175     


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
            180                 185                 190         


Arg Ala Ser Gln Asp Val Asn Thr Ala Val Ala Trp Tyr Gln Gln Lys 
        195                 200                 205             


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu Tyr 
    210                 215                 220                 


Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe 
225                 230                 235                 240 


Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
                245                 250                 255     


Cys Gln Gln His Tyr Thr Thr Pro Pro Thr Phe Gly Gln Gly Thr Lys 
            260                 265                 270         


Val Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro 
        275                 280                 285             


Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu 
    290                 295                 300                 


Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp 
305                 310                 315                 320 


Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp 
                325                 330                 335     


Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys 
            340                 345                 350         


Ala Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln 
        355                 360                 365             


Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys 
    370                 375                 380             


<210>  9
<211>  169
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  N-terminal amino acid sequence derived from Synechocystis sp. 
       DnaB that including 6xHis sequence

<400>  9

Met Ala Ile Ser Gly Asp Ser Leu Ile Ser Leu Ala Ser Thr Gly Lys 
1               5                   10                  15      


Arg Val Ser Ile Lys Asp Leu Leu Asp Glu Lys Asp Phe Glu Ile Trp 
            20                  25                  30          


Ala Ile Asn Glu Gln Thr Met Lys Leu Glu Ser Ala Lys Val Ser Arg 
        35                  40                  45              


Val Phe Cys Thr Gly Lys Lys Leu Val Tyr Ile Leu Lys Thr Arg Leu 
    50                  55                  60                  


Gly Arg Thr Ile Lys Ala Thr Ala Asn His Arg Phe Leu Thr Ile Asp 
65                  70                  75                  80  


Gly Trp Lys Arg Leu Asp Glu Leu Ser Leu Lys Glu His Ile Ala Leu 
                85                  90                  95      


Pro Arg Lys Leu Glu Ser Ser Ser Leu Gln Leu Ala Ser Gly His His 
            100                 105                 110         


His His His His Gly Gly Ser Gly Ser Ser Pro Glu Ile Glu Lys Leu 
        115                 120                 125             


Ser Gln Ser Asp Ile Tyr Trp Asp Ser Ile Val Ser Ile Thr Glu Thr 
    130                 135                 140                 


Gly Val Glu Glu Val Phe Asp Leu Thr Val Pro Gly Pro His Asn Phe 
145                 150                 155                 160 


Val Ala Asn Asp Ile Ile Val His Asn 
                165                 


